DSS Imagetech, a leader in molecular diagnostics, life sciences, and biotechnology, has launched Hanahealth, a specialized vertical dedicated to IVF and Assisted Reproductive Technology (ART) solutions across India.
“The burden of infertility continues to be significant, driving the need for advanced ART solutions. With DSS Imagetech’s 80+ years of biotech legacy, Hanahealth brings innovation, product depth, and institutional trust into a dedicated IVF brand,” said A. R. Ghatak, Vice President, IVF Division, Hanahealth by DSS.
Positioning itself as a single, trusted source for IVF instruments, culture media, and training, Hanahealth offers embryologists and fertility specialists a comprehensive IVF portfolio—from advanced microscopes and micromanipulation tools to world-class culture media and time-lapse incubators.
Hanahealth is also integrating AI-powered embryo assessment tools with time-lapse incubation, enabling fertility clinics to standardize embryo selection and improve success rates. “Global evidence shows AI supports embryo viability prediction. With India’s broader AI adoption push, Hanahealth combines optics and imaging strengths with digital readiness,” said Sindhoora Rao B, Embryologist – Application Specialist, Hanahealth.
According to the UNFPA (June 2025), India’s fertility rate has fallen from nearly 5 children per woman in 1970 to about 2 today, with infertility contributing to 13% of cases. The Indian IVF services market, valued at $1.4 million in 2024, is projected to reach $4.9 million by 2034 at a CAGR of 16.23% (Customs Market Insights).
Founded in 1998 and headquartered in New Delhi, DSS Imagetech Pvt. Ltd. continues its vision of being “Inspired by Technology”, providing cutting-edge microscopy, diagnostics, medical equipment, and R&D solutions across healthcare and life sciences.